AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Adenovirus encapsulation curbs immune response problems of gene therapy.

Vaccine Weekly

| January 01, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 JAN 1 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Enclosing adenovirus-based recombinant gene therapies in alginate microspheres could be one way to eliminate undesirable immune response, according to a study performed at Purdue University in West Lafayette, Indiana.

"Preexisting immunity against adenoviruses may compromise the efficacy of adenoviral vectors for vaccination and gene therapy," G. Sailaja and colleagues advised in the December 2002 edition of Gene Therapy.

The investigators suggested encapsulation might overcome the problem of preexisting immune response after studying alginate microparticles containing adenoviruses encoding for beta-galactosidase (LacZ) in several laboratory animals.

To examine encapsulation efficacy, Sailaja and fellow investigators first inoculated mice with human adenovirus type 5 (HAd5) to generate antibodies, and then challenged the animals with encapsulated or nonencapsulated vectors.

HAd5 antibody-primed animals exhibited lower LacZ expression after inoculation with nonencapsulated vector than did nonprimed animals who received the same vaccination. This suggested heightened immune system activity in the primed animals, according to Sailaja and coauthors (Encapsulation of recombinant adenovirus into alginate microspheres ...

Related articles from newspapers, magazines, journals, and more
SAN DIEGO REGIONAL CANCER CENTER AND THE IMMUNE RESPONSE CORPORATION BEGIN GENE...
Press release article from: PR Newswire June 15, 1995 700+ words
...gift) and The Immune Response Corporation...potential colon cancer gene therapy vaccine. This...exclusively to The Immune Response Corporation. The Immune Response Corporation is...products utilizing gene therapy, antisense and...
Adenovirus encapsulation curbs immune response problems of gene therapy.
Newspaper article from: Gene Therapy Weekly January 2, 2003 700+ words
...vaccination and gene therapy," G. Sailaja...2002 edition of Gene Therapy. The investigators...preexisting immune response after studying...to circumvent immune response activity This...prepared by Gene Therapy Weekly editors...
Cell Genesys Reports Anti-Tumor Immune Response Following Prostate Cancer Gene...
Press release article from: PR Newswire May 19, 1998 700+ words
...of the company's GVAX(TM) gene therapy vaccine against prostate cancer demonstrated an anti-tumor immune response. The preliminary results demonstrate...second generation GVAX(TM) gene therapy product now being tested in prostate...
Schering-Plough and Immune Response in Agreement to Develop Hepatitis Gene...
Press release article from: PR Newswire July 9, 1998 700+ words
...to combine Immune Response's proprietary...to develop gene therapy products...and future gene therapy technology developed by Immune Response in conjunction...collaboration between Immune Response and Schering...strengthens our gene therapy ...
Gene therapy escapes the immune response. (new gene delivery method)(Science...
Magazine article from: Science News Travis, John September 2, 1995 700+ words
...allow repeated gene therapy efforts in the...largest obstacles to gene therapy is the immune response, a usually welcome...predicts Wilson, gene therapy groups will explore...safely suppress the immune response against virus...
AMT Makes Important Advance in the Development of its Gene Therapy for...
Press release article from: M2 Presswire June 10, 2008 700+ words
...Development of its Gene Therapy for Hemophilia...Technology to Prevent Immune Response(C)1994...field of human gene therapy, today announced...development of an immune response, and thereby...effectiveness of the gene therapy for Hemophilia...
AMT Makes Important Advance in the Development of its Gene Therapy for...
Press release article from: PR Newswire June 10, 2008 700+ words
...Factor IX. Gene therapy can be used...to prevent an immune response against the...vectors used in gene therapy. With this...development of an immune response, and thereby...effectiveness of the gene therapy for Hemophilia...
THE IMMUNE RESPONSE CORPORATION'S WHOLLY OWNED SUBSIDIARY, TARGETECH INC.,...
Press release article from: PR Newswire November 30, 1992 700+ words
...scientific officer of Immune Response, commented that...technology may help gene therapy evolve from an in vitro...hospital setting." The Immune Response Corporation, through...human diseases through gene therapy. The technology is...
GenStar's Genetically Modified HIV Virus Shown to Stimulate Anti-HIV Immune...
Press release article from: Business Wire June 5, 2000 700+ words
...American Society of Gene Therapy GenStar Therapeutics...American Society of Gene Therapy in Denver, Colorado...induced a specific immune response against the virus that...related lentiviral gene therapy technologies from Allegro...
Cell Genesys Reports Additional Successful Preclinical Studies of Hemophilia...
Press release article from: PR Newswire June 5, 2000 700+ words
...administration of hemophilia gene therapy. The therapy, which was...a potentially harmful immune response against the gene therapy, as measured by the development...the American Society for Gene Therapy Conference by Brian A...
For more facts and information, see all results

Source: HighBeam Research, Adenovirus encapsulation curbs immune response problems of gene...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA